Both in Biotechnology
Anavex Life Sciences vs Outlook Therapeutics
Over the past year AVXL returned −84.5% and OTLK returned −64.6%; their daily moves had a correlation of 0.00.
AVXL −84.5% OTLK −64.6%Growth of $1, one year, split-adjusted
| Metric | AVXL | OTLK |
|---|---|---|
| Price | $1.20 | $0.4600 |
| Market cap | $111.2M | $112.0M |
| Today | +5.26% | −1.96% |
| 1 month | −27.1% | −22.8% |
| 6 months | −64.3% | +90.3% |
| Year to date | −66.3% | −70.9% |
| 1 year | −84.9% | −63.5% |
| Revenue growth (YoY) | — | −99.4% |
| Gross margin | — | −95.0% |
| Net margin | — | −233554.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $118.3M | -$7.0M |
| Dividend yield | — | — |
| Volatility (60d) | 74.0% | 89.0% |
| Short % of float | 14.0% | 39.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).